CPN1 and myeloid sarcoma: In 2006, Bagos et al.[57] performed a meta-analysis of 26 studies involving 1332 MS patients and 1464 controls, and concluded that "Even though the presence of Cpn is clearly more likely in MS patients, these findings are insufficient to establish an etiologic relation."